Literature DB >> 1628425

Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome.

W G Shattles1, S M Brookes, P J Venables, D A Clark, R N Maini.   

Abstract

To examine the possible involvement of retroviruses in Sjögren's syndrome (SS), labial salivary gland sections from 99 individuals were probed with three MoAbs to core (gag) proteins of human T cell leukaemia virus-1 (HTLV-1) and two MoAbs to HIV-1. Sections from 31% of 39 patients with primary SS (pSS) contained an epithelial cytoplasmic protein reactive with a MoAb (197) to the p19 group specific antigen (gag) of HTLV-1. The antigen was also detected in samples from 24% of 17 patients with rheumatoid arthritis (RA) and SS, 21% of 14 patients with sicca symptoms and 12.5% of 16 patients with other connective tissue diseases. It was not found in the salivary glands of 13 normal controls. A second MoAb to p19 gag, a MoAb to the p24 gag of HTLV-1 and MoAbs to HIV-1 p17 and p24 gags gave negative reactions. Serum antibodies to HTLV-1 were negative, confirming that the antigen was not part of HTLV-1. The antigen showed properties consistent with an endogenous retrovirus in that it was absent in healthy tissues or resting cells but inducible by stimulation with phytohaemagglutinin (PHA) or interferon-gamma (IFN-gamma). It appeared to be distinct from the endogenous retroviral sequence HRES-1. These data suggest the presence of an endogenous retrovirus in salivary gland epithelium which could contribute to the chronic inflammation of SS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628425      PMCID: PMC1554392          DOI: 10.1111/j.1365-2249.1992.tb06875.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Retroviruses and autoimmunity.

Authors:  A M Krieg; A D Steinberg
Journal:  J Autoimmun       Date:  1990-04       Impact factor: 7.094

Review 2.  Lymphoma and other HIV-associated malignancies.

Authors:  P L Myskowski; D J Straus; B Safai
Journal:  J Am Acad Dermatol       Date:  1990-06       Impact factor: 11.527

3.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

4.  A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.

Authors:  N Talal; R F Garry; P H Schur; S Alexander; M J Dauphinée; I H Livas; A Ballester; M Takei; H Dang
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 5.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

6.  Sjögren's syndrome. Proposed criteria for classification.

Authors:  R I Fox; C A Robinson; J G Curd; F Kozin; F V Howell
Journal:  Arthritis Rheum       Date:  1986-05

7.  Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus erythematosus.

Authors:  L S de Clerck; M M Couttenye; M E de Broe; W J Stevens
Journal:  Arthritis Rheum       Date:  1988-02

Review 8.  Unraveling the structure of the intermediate filaments.

Authors:  E Fuchs; I Hanukoglu
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

9.  Definition and clinical relevance of antibodies to nuclear ribonucleoprotein and other nuclear antigens in patients with cryptogenic fibrosing alveolitis.

Authors:  J R Chapman; P J Charles; P J Venables; P J Thompson; P L Haslam; R N Maini; M E Turner Warwick
Journal:  Am Rev Respir Dis       Date:  1984-09

10.  Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy).

Authors:  N Talal; M J Dauphinée; H Dang; S S Alexander; D J Hart; R F Garry
Journal:  Arthritis Rheum       Date:  1990-06
View more
  17 in total

Review 1.  Superantigens in insulin-dependent diabetes mellitus.

Authors:  P Luppi; M Trucco
Journal:  Springer Semin Immunopathol       Date:  1996

Review 2.  Is Sjögren's syndrome a retroviral disease?

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2011-04-13       Impact factor: 5.156

Review 3.  Viruses and salivary gland disease (SGD): lessons from HIV SGD.

Authors:  L Jeffers; J Y Webster-Cyriaque
Journal:  Adv Dent Res       Date:  2011-04

4.  Chronic dacryosialadenitis in HTLV I associated myelopathy.

Authors:  L Cartier; J L Castillo; J G Cea; R Villagra
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

5.  A novel exogenous retrovirus sequence identified in humans.

Authors:  D J Griffiths; P J Venables; R A Weiss; M T Boyd
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Retrovirus in salivary glands from patients with Sjögren's syndrome.

Authors:  S Yamano; J N Renard; F Mizuno; Y Narita; Y Uchida; H Higashiyama; H Sakurai; I Saito
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

7.  Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to rats.

Authors:  Michael Shohat; Batya Shohat; Anat Achiron
Journal:  Med Microbiol Immunol       Date:  2005-10-12       Impact factor: 3.402

Review 8.  Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease.

Authors:  H B Urnovitz; W H Murphy
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

9.  Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.

Authors:  A Achiron; O Pinhas-Hamiel; Y Barak; L Doll; D Offen; R Djaldetti; G Frankel; B Shohat
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 10.  Genetic background and environment contribute synergistically to the onset of autoimmune diseases.

Authors:  P Luppi; M R Rossiello; S Faas; M Trucco
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.